• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Amgen, Inc.

NASDAQ:AMGN

$69.05 -$0.05 (-0.07%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

8 Biotechnology Stocks With Good Liquidity That Analysts Rate As Buy

5/25/2012 by Seeking Alpha

9 Cash-Hoarding Large Cap Stocks With Buy Or Better Ratings

5/24/2012 by Seeking Alpha

Pfizer Updates: Zithromax Associated With Heart Deaths; Xalcori Successful

5/21/2012 by Trefis

Where the Stock and Bond Bargains Are Hiding

5/20/2012 by Smart Money

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP

5/18/2012 by 247wallst

Merck KGaA's Erbitux Faces Hurdle - Analyst Blog

5/17/2012 by Nasdaq

Amgen Presents Oncology Data - Analyst Blog

5/17/2012 by Nasdaq

When the Going Gets Tough, the Greeks Run on Their Banks

5/16/2012 by Minyanville

How High Can Biogen Idec Fly?

5/16/2012 by DailyFinance

Pfizer's Rheumatoid Arthritis Pill Endorsed by FDA Panel

5/10/2012 by Minyanville

Amgen Sells $3 Billion In US Bond Market

5/10/2012 by Smart Money

UPDATE: Companies Pour Into High-Grade Corporate Bond Market

5/10/2012 by Smart Money

Checking Amgen's Intangibles

5/9/2012 by DailyFinance

3 Dow Stocks Have Big Days

5/9/2012 by DailyFinance

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

5/8/2012 by 247wallst

Pfizer's Must-Win FDA Vote

5/8/2012 by DailyFinance

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg

5/4/2012 by Smart Money

Pfizer Plan to Buy Stock, Raise Dividends Overshadows Growth Strategy [UPDATE]

5/4/2012 by Minyanville

Best of the Blogs, Biotech: How Much Money Do the Top Pharma CEOs Make?

5/3/2012 by Minyanville

Pfizer Looks Fine Post-Tornado

5/2/2012 by DailyFinance

2nd UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales

5/1/2012 by Smart Money

3rd UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales

5/1/2012 by Smart Money

Pfizer Plan to Buy Stock, Raise Dividends Overshadows Growth Strategy

5/1/2012 by Minyanville

Vivus Wins FDA Approval

4/30/2012 by Minyanville

WSJ BLOG/Health: A.M. Vitals: U.S. Officials Defend Testing Regime for Mad Cow Disease

4/27/2012 by Smart Money

Do Apple earnings augur a tech comeback?

4/26/2012 by MarketWatch

Anemic Growth? Not From These Drugs.

4/26/2012 by DailyFinance

Amgen Beats but Maintains Outlook - Analyst Blog

4/25/2012 by Nasdaq

Amgen To Buy Mustafa Nevzat For $700 Million

4/25/2012 by Smart Money

Will the FDA Expand the Label for Amgen's Xgeva?

4/25/2012 by DailyFinance

Is Affymax the Perfect Stock?

4/25/2012 by DailyFinance

Apple, Juniper results to be in focus after hours

4/24/2012 by MarketWatch

Amgen Kicks Off Week of Big Biotech Earnings

4/24/2012 by Minyanville

Stocks On the Rebound, Dow Eyes Potential Head-and-Shoulders Support

4/24/2012 by Nasdaq

UPDATE: Amgen 1Q Profit Rises 5.2% On Broad Sales Growth

4/24/2012 by Smart Money

Amgen 1Q Profit Rises 5.2% On Broad Sales Growth

4/24/2012 by Smart Money

Amgen first-quarter profit rises 5.2%

4/24/2012 by MarketWatch

U.S. stock gains hinge on Apple, blue-chip results

4/21/2012 by MarketWatch

MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results

4/21/2012 by Smart Money

Top Earnings Previews For Early In The Week Ahead (COP, ILMN, NFLX, TXN, AMGN, AAPL, T, BIDU, COH, J

4/20/2012 by 247wallst
See More Articles...